Showing 1 - 10 of 268
This study investigates hospitals’ dynamic incentives to select patients when hospitals are remunerated according to a prospective payment system of the DRG type. Given that prices typically reflect past average costs, we use a discrete-time dynamic framework. Patients differ in severity...
Persistent link: https://www.econbiz.de/10010412307
In this paper we present a theory of health investment when there are multiple causes of death. Since there are several … risks competing for one's life, the health investments in avoiding different causes of death are not independent in general … make such health investments normal goods, non-Giffen goods, gross complements to one another, and have a positive risk …
Persistent link: https://www.econbiz.de/10011409040
We study the impact of insurance on the amount of fraud in a physician-patient relationship. In a market for credence …
Persistent link: https://www.econbiz.de/10011409200
The family plays a central role in decisions relative to the provision of long term care (LTC). We develop a model of family bargaining to study the impact of the distribution of bargaining power within the family on the choices of nursing homes, and on the location and prices chosen by nursing...
Persistent link: https://www.econbiz.de/10011474663
We develop a dynamic model of hospital competition where (i) waiting times increase if demand exceeds supply; (ii) patients choose a hospital based in part on waiting times; and (iii) hospitals incur waiting time penalties. We show that, whereas policies based on penalties will lead to lower...
Persistent link: https://www.econbiz.de/10012024415
(absence) of parallel imports. Our results suggest that price regulation might improve static efficiency without being harmful … for dynamic efficiency in the presence of parallel imports. …
Persistent link: https://www.econbiz.de/10011305382
Recent political events have thrust the bulk negotiation of drug prices by Medicare and Medicaid back into the spotlight. Yet, even if politically feasible, there is no clear framework for negotiating prices of new drugs with uncertain target populations - for example, due to imprecise estimates...
Persistent link: https://www.econbiz.de/10011788784
A central theme in the international debate on genetic testing concerns the extent to which insurance companies should … be allowed to use genetic information in their design of insurance contracts. We analyze this issue within a model with …
Persistent link: https://www.econbiz.de/10011402443
This paper investigates competition between health insurance companies under different financing regulations. We … consumer welfare than premia competition when switching between insurance companies is costly. -- health care reform … consider two alternatives advanced in recent German health care reform discussions: competition by contribution rates (health …
Persistent link: https://www.econbiz.de/10008698408
We analyse the effect of competition on quality in hospital markets with regulated prices, considering both the effect of (i) introducing competition (monopoly versus competition) and (ii) increasing competition through lower transportation costs (increased substitutability) or a higher number...
Persistent link: https://www.econbiz.de/10003850156